Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 1.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.89 | 52 Week High | $3.89 | |||
| Open | $1.91 | 52 Week Low | $1.85 | |||
| Day High | $1.92 | P/E | N/A | |||
| Day Low | $1.83 | EPS | $0.00 | |||
| Volume | 11,166 | |||||
